Key Insights

Highlights

Success Rate

50% trial completion

Treatment Research

9 treatments under study, led by Sweptsource Ss Oct Angiography

Research Leaders

7 sponsors active, led by Chang Gung Memorial Hospital

Related Conditions

Often studied with 15 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 75/100

Termination Rate

16.7%

1 terminated out of 6 trials

Success Rate

50.0%

-36.6% vs benchmark

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

50% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (2)
Phase 4 (1)

Trial Status

Recruiting2
Completed1
Not Yet Recruiting1
Terminated1
Enrolling By Invitation1

Trial Success Rate

50.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (6)

Research Network

Common Treatments

  • Sweptsource Ss Oct Angiography1
  • Blood Pressure Measurement1
  • Pars Plana Vitrectomy With A 18 Mm Short Vitrector1
  • Octa1
  • Spectraldomain Sd Oct Angiography1

Active Sponsors

  • Chang Gung Memorial Hospital1
  • University of California, Los Angeles1
  • Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts1
  • Fondation Ophtalmologique Adolphe de Rothschild1
  • Greater Houston Retina Research1

Top Investigators

Related Conditions

  • Retinal Disease2
  • Other Retinal Disorders1
  • Retinal Vein Occlusion1
  • Diabetic Retinopathy1
  • Vitreous Disorder1

Activity Timeline